During pregnancy, women experience numerous physiological changes but, to date, 2 there is limited published data that characterize accompanying changes in gene expression over 3 pregnancy. This study sought to characterize the complexity of gene expression over the course 4 of pregnancy among women with healthy pregnancies. Subjects provided a venous blood sample 5 during early (6-15 weeks) and late (22-33 weeks) pregnancy, which was used to isolate 6 peripheral blood mononuclear cells prior to RNA extraction. Gene expression was examined for 7 63 women with uncomplicated, term deliveries. We evaluated the association between weeks 8 gestation at sample collection and expression of each transcript. Of the 16,311 transcripts 9 evaluated, 439 changed over pregnancy after a Bonferroni correction to account for multiple 1 0 comparisons. Genes whose expression changed over pregnancy were associated with oxygen 1 1 transport, the immune system, and host response to bacteria. Characterization of changes in gene 1 2 expression over the course of healthy term pregnancies may enable the identification of genes 1 3 whose expression predicts complications or adverse outcomes of pregnancy.
5 30 days. Despite this, no woman delivered a neonate that was small for gestational age or 6 4 experienced any complications over their pregnancies (see Methods for additional details). Changes in cell proportions over pregnancy 6 9 Studies have reported changes in a range of cell types and immune activation profiles 7 0 over pregnancy [7] [8] [9] . Consistent with those previous reports, we observed changes in the 7 1
proportion of cell types in maternal PBMCs over the course of pregnancy. There was a Benjamini-Hochberg adjustment. The x-axis represents weeks gestation at sample collection, and the y-axis represents the log2- DEFA1B (ILMN_2102721; p=1.79x10 -13 ). In contextualizing our study findings with the existing literature, we attempted to 1 2 0 compare the genes whose expression levels change in healthy pregnancies to those that have 1 2 1 been reported to change in women with autoimmune disorders. In some cases, complete gene This shift has been further explored in studies of autoimmune disorders and pregnancy, with 1 4 8 several pathways involved being identified that may contribute to reductions, or in other cases, 1 4 9 increases in autoimmune symptoms during pregnancy [3] [4] [5] [6] . However, such studies often do not 1 5 0 control for differences in cellular proportions, increasing the chance that they will identify genes 1 5 1 whose expression is not entirely attributable to the disorder of interest or are otherwise difficult 1 5 2 to interpret. Thus, it is vital for future studies to estimate and adjust for cellular heterogeneity, as 1 1 play vary during pregnancy. Finally, we did not have access to samples spanning the entirety of 2 0 0 pregnancy, including before 8 weeks and after 33 weeks gestation. sample was collected at 6-15 weeks, and the second sample was collected at 22-33 weeks. During each prenatal visit, an additional 12 mL of venous blood was drawn using the same 2 3 6 needle stick as for the routine blood draws. PBMCs were isolated from whole blood using a 2 3 7
Ficoll density gradient and were stored in AllProtect Buffer (Qiagen) at -80 °C until a For each subject, gene expression was assessed for ~47,000 transcripts using the 2 4 4
HumanHT-12 v4 BeadChip (Illumina). Briefly, 750 ng of RNA was directly hybridized to the Omnibus, GEOXXXX. DNA methylation was interrogated for each subject using either the 2 5 4
HumanMethylation450 or MethylationEPIC BeadChip, which measures methylated and 2 5 5 unmethylated signal for >450,000 and >850,000 CpG sites across the genome, respectively. with low signal or missing data for greater than 10% of samples was removed, and any sample 2 5 8 with missing data for greater than 5% of CpG sites was removed. Cross-reactive probes were 2 5 9 removed [31]. Following quality control, 449,094 probes were included in subsequent analyses. Expression Omnibus, GEOXXXX. We used linear mixed-effects modeling implemented in the R package "nlme" to 2 6 9
interrogate associations between gene expression and weeks gestation at sample instead of a covariate adjustment as only a few cellular subtypes are well defined using current model. Figure S1 shows the associations between each surrogate variable and common 2 7 6 confounders. A random effects term was included in the model to account for repeated sampling 2 7 7 of the same person. A Bonferroni correction was applied to account for multiple testing. Pathway analysis for associated genes was performed using DAVID [36]. We are grateful to the participants enrolled in this cohort who provided samples and medical : . 
